Financials
- Market Capitalization 2.72 B
- Employee 357
- Founded 2009
- CEO N/A
- Website www.nurixtx.com
- Headquarter Delaware, United States
- FIGI BBG00SDJ8M78
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1741 | ZLAB Zai Lab Limited - American Depositary Shares | 26.08 USD | -2.76% | +2.35% | +42.67% | -2.29% | 2.93 B USD | ||
| 1748 | ALMS Alumis Inc. - Common Stock | 22.38 USD | -3.58% | -5.53% | -16.96% | +396.23% | 2.90 B USD | ||
| 1799 | ATAI AtaiBeckley Inc. - Common Stock | 7.29 USD | -0.82% | -1.35% | +1.53% | +84.56% | 2.70 B USD | ||
| 1810 | SLS SELLAS Life Sciences Group, Inc. - Common Stock | 13.21 USD | -13.15% | -14.66% | +33.03% | +588.02% | 2.67 B USD |
Frequently asked questions about Nurix Therapeutics, Inc. Common stock
What is the Nurix Therapeutics, Inc. Common stock stock price today?
The current price of Nurix Therapeutics, Inc. Common stock (NRIX) is 26.21. Over the past 24 hours, the stock has changed by -2.49%. Follow the NRIX chart for real-time price dynamics.
What is the stock ticker of Nurix Therapeutics, Inc. Common stock?
Nurix Therapeutics, Inc. Common stock trades under the ticker NRIX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Nurix Therapeutics, Inc. Common stock stock going up?
NRIX has changed by -0.61% over the last week, +9.67% over the last month, and +133.81% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Nurix Therapeutics, Inc. Common stock?
Nurix Therapeutics, Inc. Common stock currently has a market capitalization of 2.72 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Nurix Therapeutics, Inc. Common stock earnings last quarter?
Last quarter, Nurix Therapeutics, Inc. Common stock reported earnings of -0.81 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Nurix Therapeutics, Inc. Common stock revenue for the last quarter?
Nurix Therapeutics, Inc. Common stock reported quarterly revenue of 9.04 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Nurix Therapeutics, Inc. Common stock net income for the last quarter?
Nurix Therapeutics, Inc. Common stock reported net income of -89.53 M for the last quarter. The previous quarter showed -87.17 M, which means net income changed by -2.71%.
How many employees does Nurix Therapeutics, Inc. Common stock have?
As of the latest available data, Nurix Therapeutics, Inc. Common stock has 357 employees. Workforce size can provide additional context about the company's scale and operations.
What is Nurix Therapeutics, Inc. Common stock EBITDA?
Nurix Therapeutics, Inc. Common stock EBITDA is -95.76 M, and its EBITDA margin is -1 058.95%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Nurix Therapeutics, Inc. Common stock stock?
You can buy Nurix Therapeutics, Inc. Common stock (NRIX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Nurix Therapeutics, Inc. Common stock stock?
Investing in Nurix Therapeutics, Inc. Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NRIX chart and related analysis on metatrader.com as part of your research.